2026 Simon Gibbons: Biology and Biochemistry Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Biology and Biochemistry	69	7285	6719	561	521	267	21180

Overview

Simon Gibbons is affiliated with the University of East Anglia in the United Kingdom. Their research spans multiple fields including Biochemistry, Genetics and Molecular Biology, and Medicine, with notable subfields in Molecular Biology, Pharmacology, Plant Science, Organic Chemistry, and Food Science.

The scientist's work addresses several key topics, such as:

Natural product bioactivities and synthesis
Antibiotic Resistance in Bacteria
Bioactive Compounds and Antitumor Agents
Phytochemistry and Biological Activities
Microbial Natural Products and Biosynthesis
Phytochemical compounds biological activities
Phenothiazines and Benzothiazines Synthesis and Activities

Simon Gibbons has published research in a variety of venues, frequently contributing to:

Phytotherapy Research
Journal of Natural Products
Molecules
International Journal of Antimicrobial Agents
Preprints.org

Recent notable papers include:

"Natural products in drug discovery: advances and opportunities," 2021, published in Nature Reviews Drug Discovery
"Phytochemicals in Drug Discovery-A Confluence of Tradition and Innovation," 2024, published in International Journal of Molecular Sciences
"Synergism of sophoraflavanone G with norfloxacin against effluxing antibiotic-resistant Staphylococcus aureus," 2020, published in International Journal of Antimicrobial Agents
"The Phytochemistry and Pharmacology of Hypericum," 2020, published in Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products
"Bioactive Compounds Produced by Endophytic Microorganisms Associated with Bryophytes-The 'Bryendophytes'," 2023, published in Molecules

Simon Gibbons has also contributed to a substantial number of book publications, primarily with Springer Science+Business Media, including:

Progress in the Chemistry of Organic Natural Products 114 (2021)
Progress in the Chemistry of Organic Natural Products 118 (2022)
Progress in the Chemistry of Organic Natural Products 116 (2021)
Progress in the Chemistry of Organic Natural Products 112 (2020)
Naturally Occurring Organohalogen Compounds (2023)
Progress in the Chemistry of Organic Natural Products 115 (2021)
Progress in the Chemistry of Organic Natural Products 113 (2020)
Ancistrocladus Naphthylisoquinoline Alkaloids (2023)
Modern Photocatalytic Strategies in Natural Product Synthesis (2023)
Neurotrophic Natural Products (2024)

The scientist collaborates frequently with a number of co-authors, including:

A. Douglas Kinghorn
Heinz Falk
Yoshinori Asakawa
Ji-Kai Liu
Ahmed Al-Harrasi

Best Publications

Natural products in drug discovery: advances and opportunities.

Atanas G Atanasov;Sergey B Zotchev;Verena M Dirsch

4633
Citations
Bacterial efflux pump inhibitors from natural sources

Michael Stavri;Laura J. V. Piddock;Simon Gibbons

709
Citations
Anti-staphylococcal plant natural products

Simon Gibbons

685
Citations
Antibacterial and resistance modifying activity of Rosmarinus officinalis

Moyosoluwa Oluwatuyi;Glenn W. Kaatz;Simon Gibbons

530
Citations
Echinacea species (Echinacea angustifolia (DC.) hell., Echinacea pallida (nutt.) nutt., Echinacea purpurea (L.) Moench) : a review of their chemistry, pharmacology and clinical properties

Joanne Barnes;Linda A Anderson;Simon Gibbons;J David Phillipson

518
Citations
Fundamentals of Pharmacognosy and Phytotherapy

Michael Heinrich;A. Douglas Kinghorn foreword;J. David Phillipson epilogue;illustrations by Debbie Maizels

472
Citations
Ethnopharmacology in drug discovery: an analysis of its role and potential contribution

Michael Heinrich;Simon Gibbons

384
Citations
Plants as a source of bacterial resistance modulators and anti-infective agents

Simon Gibbons

324
Citations
Phytochemicals for bacterial resistance--strengths, weaknesses and opportunities.

Simon Gibbons

300
Citations
The effect of reserpine, a modulator of multidrug efflux pumps, on the in vitro activity of tetracycline against clinical isolates of methicillin resistant Staphylococcus aureus (MRSA) possessing the tet(K) determinant.

Simon Gibbons;E. E. Udo

278
Citations
A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus

Simon Gibbons;Moyosoluwa Oluwatuyi;Glenn W. Kaatz

264
Citations
Naturally derived anti-HIV agents.

Kaleab Asres;Ameha Seyoum;Ciddi Veeresham;Franz Bucar

251
Citations
The anti-staphylococcal activity of Angelica dahurica (Bai Zhi)

Doris Lechner;Michael Stavri;Moyosoluwa Oluwatuyi;Rogelio Pereda-Miranda

248
Citations
An analysis of the 'legal high' mephedrone.

Simon Gibbons;Mire Zloh

219
Citations
Plant phenolic compounds as ethidium bromide efflux inhibitors in Mycobacterium smegmatis

Doris Lechner;Simon Gibbons;Franz Bucar

200
Citations
Neurochemical profiles of some novel psychoactive substances.

Les Iversen;Simon Gibbons;Ric Treble;Vincent Setola

188
Citations
Antibacterials and modulators of bacterial resistance from the immature cones of Chamaecyparis lawsoniana

Eileen C.J. Smith;Elizabeth M. Williamson;Neale Wareham;Glenn W. Kaatz

184
Citations
‘Legal Highs’ – novel and emerging psychoactive drugs: a chemical overview for the toxicologist

Simon Gibbons

177
Citations
The ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptor.

Bryan L. Roth;Simon Gibbons;Warunya Arunotayanun;Xi Ping Huang

170
Citations
Microbial Efflux Systems and Inhibitors: Approaches to Drug Discovery and the Challenge of Clinical Implementation

Christina Kourtesi;Anthony R Ball;Ying-Ying Huang;Sanjay M Jachak

168
Citations